Risk of low-energy hip, wrist, and upper arm fractures among current and previous users of hormone replacement therapy: The Danish Nurse Cohort Study

European Journal of Epidemiology

Volumn 19, Issue 12, 2004, Pages 1089-1095

  Hundrup, Yrsa Andersen ^a   Høidrup, Susanne ^b   Ekholm, Ola ^a   Davidsen, Michael ^a   Obel, Erik Bernhard ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b The Capital Region   (Denmark)

Author keywords

Hormone replacement therapy; Low energy fractures; Osteoporosis; Prospective cohort study

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DENMARK; ENERGY; FEMALE; HAZARD ASSESSMENT; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; HUMERUS FRACTURE; LIFESTYLE; NURSE; OSTEOPOROSIS; OUTCOMES RESEARCH; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; TIME SERIES ANALYSIS; WRIST FRACTURE;

AGED; ARM; DENMARK; ESTROGEN REPLACEMENT THERAPY; FEMALE; FRACTURES, BONE; HIP FRACTURES; HUMANS; MIDDLE AGED; NURSES; OSTEOPOROSIS, POSTMENOPAUSAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; WRIST;

EID: 13644255269     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10654-004-2173-y     Document Type: Article

References (22)

1. Nilas L, Christiansen C. Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 1987; 65: 697-702.
2. Kanis JA. The incidence of hip fracture in Europe. Osteoporosis Int 1993; Suppl. 1: 10-15.
3. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K-E, Transbcl I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273-279.
4. Eiken P, Kolthoff N, Nielsen NS. Effect of 10 year's hormone replacement therapy on bone mineral content in postmenopausal women. Bone 1996; 19(5): 191S-193S.
5. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on bone mineral density. Results from the postmenopausal oestrogen/progestin interventions (PEPI) trial. JAMA 1996; 276: 1389-1396.
6. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-1036.
7. Maxim P, Ettinger B, Spitalny GM. Fracture protection provided by long-term estrogen treatment. Osteoporos Int 1995; 5: 23-29.
8. Høidrup S, Grcnbæk M, Pedersen AT, Lauritzen JB, Gottschau A, Schroll M. Hormone replacement therapy and hip fracture risk - the effect modification by tobacco smoking, alcohol intake, physical activity and body mass index. Am J Epidemiol 1999; 150: 1085-1093.
9. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Ann. Intern. Med. 1995; 122: 9-16.
10. Grodstein F, Stampfer MJ, Falkeborn M, Naessén T, Persson I. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology 1999; 10: 476-480.
11. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative. Randomized controlled trial. JAMA 2002; 288: 321-333.
12. Michaëlsson K, Baron JA, Farahmand BY, Johnell O, Magnusson C, Persson P-G et al. Hormone replacement therapy and risk of hip fracture: population based case-control study. Br Med J 1998; 316: 1858-1863.
13. Johnell O, Gullberg B, Kanis JA, Allander E, Elfors A, Dequeker J et al. Risk factors for hip fracture in European women: The MEDOS Study. J. Bone Miner Res 1995; 10: 1802-1815.
14. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox CS, Ensrud K et al. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767-773.
15. NOMESKO. Nordisk Ulykkesklassifikation. 8. 1987. Ref Type: Report.
16. Torgerson DJ, Bell-Syser SEM. Hormone Replacement Therapy and prevention of nonvertebral fractures - A metaanalysis of randomized trials. JAMA 2001; 285: 2891-2897.
17. Weiss NS, Ure CL., Ballard JH, Williams Ann R, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980; 303: 1195-1198.
18. Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowitz MA. Hip fracture and the use of estrogen in postmenopausal women. The Framingham study. N Engl J Med 1987; 317: 1169-1174.
19. Schneider DL, Barrett-Connor EL, Morton DJ. Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernado Study. JAMA 1997; 277: 543-547.
20. Løkkegaard E, Johnsen SP, Heitmann BL, Stahlberg C, Pedersen AT, Obel E.B et al. The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand 2004; 83: 476-481
21. Hundrup YA, Obel EB, Rasmussen NK, Philip J. Use of hormone replacement therapy among Danish nurses in 1993. Acta Obstet Gynecol Scand 2000; 79: 194-201.
22. Hundrup YA, Høidrup S, Obel EB. The validity of self-reported fractures among Danish nurses: A comparison with fractures registered in the Danish National Hospital register. Scand J Public Health 2004; 32: 136-143.